These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 18382647)

  • 1. An Outbreak of Human Coronavirus OC43 Infection and Serological Cross-reactivity with SARS Coronavirus.
    Patrick DM; Petric M; Skowronski DM; Guasparini R; Booth TF; Krajden M; McGeer P; Bastien N; Gustafson L; Dubord J; Macdonald D; David ST; Srour LF; Parker R; Andonov A; Isaac-Renton J; Loewen N; McNabb G; McNabb A; Goh SH; Henwick S; Astell C; Guo JP; Drebot M; Tellier R; Plummer F; Brunham RC
    Can J Infect Dis Med Microbiol; 2006 Nov; 17(6):330-6. PubMed ID: 18382647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of human coronavirus OC43 and SARS-COV-2 in children with respiratory tract infection during the COVID-19 pandemic.
    Keshavarz Valian N; Pourakbari B; Asna Ashari K; Hosseinpour Sadeghi R; Mahmoudi S
    J Med Virol; 2022 Apr; 94(4):1450-1456. PubMed ID: 34786736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fully automated detection and differentiation of pandemic and endemic coronaviruses (NL63, 229E, HKU1, OC43 and SARS-CoV-2) on the hologic panther fusion.
    Cordes AK; Rehrauer WM; Accola MA; Wölk B; Hilfrich B; Heim A
    J Med Virol; 2021 Jul; 93(7):4438-4445. PubMed ID: 33350484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoreactivity characterisation of the three structural regions of the human coronavirus OC43 nucleocapsid protein by Western blot: implications for the diagnosis of coronavirus infection.
    Liang FY; Lin LC; Ying TH; Yao CW; Tang TK; Chen YW; Hou MH
    J Virol Methods; 2013 Feb; 187(2):413-20. PubMed ID: 23174159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repurposing old drugs as antiviral agents for coronaviruses.
    Yang CW; Peng TT; Hsu HY; Lee YZ; Wu SH; Lin WH; Ke YY; Hsu TA; Yeh TK; Huang WZ; Lin JH; Sytwu HK; Chen CT; Lee SJ
    Biomed J; 2020 Aug; 43(4):368-374. PubMed ID: 32563698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactive T Cells in Convalescent COVID-19 Patients With Negative SARS-CoV-2 Antibody Serology.
    Steiner S; Schwarz T; Corman VM; Sotzny F; Bauer S; Drosten C; Volk HD; Scheibenbogen C; Hanitsch LG
    Front Immunol; 2021; 12():687449. PubMed ID: 34322120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence and SARS-CoV-2 cross-reactivity of endemic coronavirus OC43 and 229E antibodies in Finnish children and adults.
    Tamminen K; Salminen M; Blazevic V
    Clin Immunol; 2021 Aug; 229():108782. PubMed ID: 34118402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronavirus Occurrence in the Household Influenza Vaccine Evaluation (HIVE) Cohort of Michigan Households: Reinfection Frequency and Serologic Responses to Seasonal and Severe Acute Respiratory Syndrome Coronaviruses.
    Petrie JG; Bazzi LA; McDermott AB; Follmann D; Esposito D; Hatcher C; Mateja A; Narpala SR; O'Connell SE; Martin ET; Monto AS
    J Infect Dis; 2021 Jul; 224(1):49-59. PubMed ID: 33755731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronavirus HKU1 and other coronavirus infections in Hong Kong.
    Lau SK; Woo PC; Yip CC; Tse H; Tsoi HW; Cheng VC; Lee P; Tang BS; Cheung CH; Lee RA; So LY; Lau YL; Chan KH; Yuen KY
    J Clin Microbiol; 2006 Jun; 44(6):2063-71. PubMed ID: 16757599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two serological approaches for detection of antibodies to SARS-CoV-2 in different scenarios: a screening tool and a point-of-care test.
    Hoste ACR; Venteo A; Fresco-Taboada A; Tapia I; Monedero A; López L; Jebbink MF; Pérez-Ramírez E; Jimenez-Clavero MA; Almonacid M; Muñoz P; Guinea J; Vela C; van der Hoek L; Rueda P; Sastre P
    Diagn Microbiol Infect Dis; 2020 Dec; 98(4):115167. PubMed ID: 32890908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Milk Antibodies Against S1 and S2 Subunits from SARS-CoV-2, HCoV-OC43, and HCoV-229E in Mothers with A Confirmed COVID-19 PCR, Viral SYMPTOMS, and Unexposed Mothers.
    Demers-Mathieu V; DaPra C; Mathijssen G; A Sela D; M Jarvinen K; Seppo A; Fels S; Medo E
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33572480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular epidemiological study of human coronavirus OC43 in Shanghai from 2009-2016].
    Yang YJ; Hu YW
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Jan; 52(1):55-61. PubMed ID: 29334709
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunity against seasonal human coronavirus OC43 mitigates fatal deterioration of COVID-19.
    Yamaguchi T; Shinagawa T; Kobata H; Nakagawa H
    Int J Infect Dis; 2021 Aug; 109():261-268. PubMed ID: 34273512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Montelukast Inhibits HCoV-OC43 Infection as a Viral Inactivator.
    Chen Y; Wang X; Shi H; Zou P
    Viruses; 2022 Apr; 14(5):. PubMed ID: 35632604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of pre-existing serological cross-reactivity against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in sub-Saharan Africa.
    Tso FY; Lidenge SJ; Peña PB; Clegg AA; Ngowi JR; Mwaiselage J; Ngalamika O; Julius P; West JT; Wood C
    Int J Infect Dis; 2021 Jan; 102():577-583. PubMed ID: 33176202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HCoV- and SARS-CoV-2 Cross-Reactive T Cells in CVID Patients.
    Steiner S; Sotzny F; Bauer S; Na IK; Schmueck-Henneresse M; Corman VM; Schwarz T; Drosten C; Wendering DJ; Behrends U; Volk HD; Scheibenbogen C; Hanitsch LG
    Front Immunol; 2020; 11():607918. PubMed ID: 33424856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Coronaviruses as the cause of respiratory infections].
    Corman VM; Lienau J; Witzenrath M
    Internist (Berl); 2019 Nov; 60(11):1136-1145. PubMed ID: 31455974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralizing and binding activities against SARS-CoV-1/2, MERS-CoV, and human coronaviruses 229E and OC43 by normal human intravenous immunoglobulin derived from healthy donors in Japan.
    Kubota-Koketsu R; Terada Y; Yunoki M; Sasaki T; Nakayama EE; Kamitani W; Shioda T
    Transfusion; 2021 Feb; 61(2):356-360. PubMed ID: 33104267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [SARS, MERS and coronavirus infections].
    Kawana A
    Nihon Rinsho; 2016 Dec; 74(12):1967-1972. PubMed ID: 30550651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variability of human coronavirus OC43-, 229E-, and NL63-like strains and their association with lower respiratory tract infections of hospitalized infants and immunocompromised patients.
    Gerna G; Campanini G; Rovida F; Percivalle E; Sarasini A; Marchi A; Baldanti F
    J Med Virol; 2006 Jul; 78(7):938-49. PubMed ID: 16721849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.